Tanaka S, Matsuda M, Nagata S, Kurata T, Nagashima K, Shizawa Y, Fukui Y
Department of Pathology, National Institute of Health, Tokyo.
Jpn J Cancer Res. 1993 Mar;84(3):279-89. doi: 10.1111/j.1349-7006.1993.tb02868.x.
An 85 kDa subunit (p85 alpha) of phosphatidylinositol 3-kinase (PI-3K) has one SH3 and two SH2 regions [SH2(N) and SH2(C)], which direct protein-protein interaction. We have established eighteen hybridomas producing monoclonal antibodies against p85 alpha to study the structure-function relationship of this protein. Epitope mapping using a series of deletion mutants expressed in E. coli showed that the monoclonal antibodies bound to at least 5 distinct epitope regions, which were well dispersed on p85 alpha except for its carboxyl-terminus. Monoclonal antibodies against amino-terminal regions and polyclonal antibodies against carboxyl-terminal regions immunoprecipitated p85 alpha expressed in human cells and in E. coli. On the other hand, monoclonal antibodies against the central part of p85 alpha failed to immunoprecipitate p85 alpha efficiently; however, they could immunoprecipitate p85 alpha mutants with deletion of either the amino- or the carboxyl-terminal region. Similar results were obtained by immunocytochemistry using confocal microscopy. These results suggested that steric hindrance prevents binding of monoclonal antibodies to the central part of p85 alpha where SH2(N) is located. The SH2(N) may have a distinct function from SH2(C), which is located at the carboxyl-terminal region and has been shown to mediate the binding of PI-3K to activated growth factor receptors.
磷脂酰肌醇3激酶(PI-3K)的一个85 kDa亚基(p85α)含有一个SH3结构域和两个SH2结构域[SH2(N)和SH2(C)],它们介导蛋白质-蛋白质相互作用。我们建立了18株产生抗p85α单克隆抗体的杂交瘤细胞株,以研究该蛋白的结构-功能关系。利用在大肠杆菌中表达的一系列缺失突变体进行表位作图分析,结果显示这些单克隆抗体可与至少5个不同的表位区域结合,这些区域在p85α上分布广泛,但不包括其羧基末端。抗氨基末端区域的单克隆抗体和抗羧基末端区域的多克隆抗体能够免疫沉淀在人细胞和大肠杆菌中表达的p85α。另一方面,抗p85α中央部分的单克隆抗体不能有效地免疫沉淀p85α;然而,它们能够免疫沉淀缺失氨基末端或羧基末端区域的p85α突变体。使用共聚焦显微镜进行免疫细胞化学分析也得到了类似的结果。这些结果表明,空间位阻阻碍了单克隆抗体与位于中央部分的p85α(其中含有SH2(N))结合。SH2(N)可能具有与位于羧基末端区域的SH2(C)不同的功能,已有研究表明SH2(C)介导PI-3K与活化的生长因子受体的结合。